Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer

NCT01832948 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Endostar
DRUG: Oxaliplatin
DRUG: Folinic acid
DRUG: 5-FU

Sponsor

Zhejiang Cancer Hospital